Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


11.03.2019

1 Ann Surg Oncol
1 Anticancer Res
1 BMC Cancer
1 Cancer Res
1 Clin Cancer Res
5 J Am Acad Dermatol
1 J Cell Physiol
1 J Clin Invest
2 J Invest Dermatol
1 Lancet Oncol
2 Melanoma Res
1 Nat Med
4 Oncogene
1 PLoS Genet
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. BLOEMENDAL M, van Willigen WW, Bol KF, Boers-Sonderen MJ, et al
    Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy.
    Ann Surg Oncol. 2019 Mar 4. pii: 10.1245/s10434-019-07274.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. RADES D, Sehmisch L, Hansen HC, Dziggel L, et al
    Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM.
    Anticancer Res. 2019;39:1501-1505.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. KRUCKEL A, Moreira A, Frohlich W, Schuler G, et al
    Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma.
    BMC Cancer. 2019;19:207.
    PubMed     Text format     Abstract available


    Cancer Res

  4. BENITO-JARDON L, Diaz-Martinez M, Arellano-Sanchez N, Vaquero-Morales P, et al
    Resistance to MAPK inhibitors in melanoma involves activation of the IGF-1R-MEK5-Erk5 pathway.
    Cancer Res. 2019 Mar 4. pii: 0008-5472.CAN-18-2762.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. YAN Y, Wongchenko MJ, Robert C, Larkin J, et al
    Genomic features of exceptional response in vemurafenib +/- cobimetinib-treated patients with BRAFV600-mutated metastatic melanoma.
    Clin Cancer Res. 2019 Mar 1. pii: 1078-0432.CCR-18-0720.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  6. YELAMOS O, Braun RP, Liopyris K, Wolner ZJ, et al
    Usefulness of dermoscopy to improve the clinical and histopathologic diagnosis of skin cancers.
    J Am Acad Dermatol. 2019;80:365-377.
    PubMed     Text format     Abstract available

  7. GRUSHCHAK S, Grant-Kels JM
    "Sweetheart, you should have that looked at:" Ethical implications of treating family members.
    J Am Acad Dermatol. 2019;80:571-573.
    PubMed     Text format    

  8. CONNOLLY KL, Giordano C, Dusza S, Busam KJ, et al
    Follicular involvement is frequent in lentigo maligna: Implications for treatment.
    J Am Acad Dermatol. 2019;80:532-537.
    PubMed     Text format     Abstract available

  9. BOESPFLUG A, Debarbieux S, Depaepe L, Chouvet B, et al
    Reply to "Comment on 'Association of subungual melanoma and subungual squamous cell carcinoma: A case series'".
    J Am Acad Dermatol. 2019;80:e63-e64.
    PubMed     Text format    

  10. ANDRE J, Haneke E
    Comment on "Association of subungual melanoma and subungual squamous cell carcinoma: A case series".
    J Am Acad Dermatol. 2019;80:e61.
    PubMed     Text format    


    J Cell Physiol

  11. TSUBAKI M, Takeda T, Obata N, Kawashima K, et al
    Combination therapy with dacarbazine and statins improved the survival rate in mice with metastatic melanoma.
    J Cell Physiol. 2019 Mar 4. doi: 10.1002/jcp.28430.
    PubMed     Text format     Abstract available


    J Clin Invest

  12. MCEVOY CR, Xu H, Smith K, Etemadmoghadam D, et al
    Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.
    J Clin Invest. 2019;130.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  13. KOBAYASHI T, Oishi K, Okamura A, Shintaro M, et al
    Regulatory B1a cells suppress melanoma tumor immunity via IL-10 production and inhibiting Th1 cytokine production in tumor-infiltrating CD8(+) T cells.
    J Invest Dermatol. 2019 Mar 2. pii: S0022-202X(19)30186.
    PubMed     Text format     Abstract available

  14. BEAULIEU D, Nijhawan RI
    Cells to Surgery Quiz: February 2018.
    J Invest Dermatol. 2018;138:e21.
    PubMed     Text format    


    Lancet Oncol

  15. FRANKE V, van Akkooi ACJ
    The extent of surgery for stage III melanoma: how much is appropriate?
    Lancet Oncol. 2019;20:e167-e174.
    PubMed     Text format     Abstract available


    Melanoma Res

  16. NUNES TWN, Filippi-Chiela EC, Callegari-Jacques SM, da Silva VD, et al
    Nuclear morphometric analysis in tissue as an objective tool with potential use to improve melanoma staging.
    Melanoma Res. 2019 Mar 4. doi: 10.1097/CMR.0000000000000594.
    PubMed     Text format     Abstract available

  17. SWAMI U, Monga V, Freesmeier M, Zhang W, et al
    Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma.
    Melanoma Res. 2019 Mar 1. doi: 10.1097/CMR.0000000000000592.
    PubMed     Text format     Abstract available


    Nat Med

  18. NEWMAN S, Fan L, Pribnow A, Silkov A, et al
    Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.
    Nat Med. 2019 Mar 4. pii: 10.1038/s41591-019-0373.
    PubMed     Text format     Abstract available


    Oncogene

  19. YANG JB, Zhao ZB, Liu QZ, Hu TD, et al
    FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.
    Oncogene. 2018;37:1192-1204.
    PubMed     Text format     Abstract available

  20. PAULITTI A, Andreuzzi E, Bizzotto D, Pellicani R, et al
    The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth.
    Oncogene. 2018;37:3399-3414.
    PubMed     Text format     Abstract available

  21. CASTEJON-GRINAN M, Herraiz C, Olivares C, Jimenez-Cervantes C, et al
    cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage.
    Oncogene. 2018;37:3631-3646.
    PubMed     Text format     Abstract available

  22. LUBRANO S, Comelli L, Piccirilli C, Marranci A, et al
    Development of a yeast-based system to identify new hBRAFV600E functional interactors.
    Oncogene. 2019;38:1355-1366.
    PubMed     Text format     Abstract available


    PLoS Genet

  23. ELLIOTT K, Bostrom M, Filges S, Lindberg M, et al
    Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers.
    PLoS Genet. 2018;14:e1007849.
    PubMed     Text format     Abstract available


    PLoS One

  24. CHO SI, Lee J, Jo G, Kim SW, et al
    Local recurrence and metastasis in patients with malignant melanomas after surgery: A single-center analysis of 202 patients in South Korea.
    PLoS One. 2019;14:e0213475.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: